OPEN-CTO: Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

Sponsor
Saint Luke's Health System (Other)
Overall Status
Completed
CT.gov ID
NCT02026466
Collaborator
Boston Scientific Corporation (Industry)
1,000
11
48
90.9
1.9

Study Details

Study Description

Brief Summary

This is an observational registry, sponsored by Saint Luke's Hospital. This study is to be conducted according to DHHS Guidelines, applicable state regulations, and local IRB policies and procedures. The overall objective is to address current gaps in knowledge regarding CTO-PCI, as a prospective, multi-center, single-arm study of 1,000 participants.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    • 1,000 participants will be enrolled into the OPEN CTO study.

    • Study coordinators will screen both men and women over the age of 18 who are admitted for an elective CTO-PCI procedure.

    • Study coordinators will be trained by the Coordinating Center at Saint Luke's Hospital of Kansas City.

    • Participants will be screened for Eligibility, and Informed Consent will be obtained.

    • Participants will also be asked to sign a Medical Records Release form, and a Billing Records Release form.

    • Detailed procedural data will be obtained by the Study Coordinator and local Principal Investigator.

    • Participants will undergo a Baseline interview.

    • These data will be entered into the electronic data capture system, Velos, which has stringent protections and quality controls.

    • Participants will have telephone follow-up interviews conducted by the centralized Follow-up Center at Saint Luke's Hospital.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    1000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion (OPEN CTO)
    Actual Study Start Date :
    Dec 1, 2013
    Actual Primary Completion Date :
    Sep 1, 2017
    Actual Study Completion Date :
    Dec 1, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    CAD with CTO

    Subjects will have Coronary Artery Disease with a diagnosed Chronic Total Occlusion: a coronary artery with TIMI flow of zero(no flow) for at least three months.

    Outcome Measures

    Primary Outcome Measures

    1. Health Status [One year]

      Quantify the baseline health status effects of CTO among patients selected for CTO-PCI and quantify the changes associated with CTO-PCI using the Hybrid Approach.

    Secondary Outcome Measures

    1. Safety and Effectiveness [One Year]

      Describe safety and effectiveness among patients receiving CTO-PCI

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subject is scheduled for a PCI procedure for at least one chronic total occlusion with TIMI antegrade flow of zero.

    • Subject is ≥ 18 years of age at the time of consent.

    Exclusion Criteria:
    • The CTO segment is in a graft

    • Female subjects with a positive quantitative or qualitative pregnancy test, in accordance with hospital policy.

    • Non-English speaking

    • Too hard of hearing to do follow-up by telephone.

    • Previously enrolled in OPEN CTO Registry

    • Currently a prisoner

    • Dementia

    • Subjects with no way contact by telephone for follow-up.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Banner Heart Hospital Mesa Arizona United States 85206
    2 Banner Good Samaritan Phoenix Arizona United States 85006
    3 Torrance Memorial Medical Center Torrance California United States 90505
    4 Alexian Brothers Medical Center Elk Grove Village Illinois United States 60007
    5 Boone Hospital Center Columbia Missouri United States 65201
    6 Saint Luke's Hospital of Kansas City Kansas City Missouri United States 64111
    7 Presbyterian Health System Hospital Albuquerque New Mexico United States 87106
    8 Columbia University Medical Center New York New York United States 10032
    9 Peace Health Sacred Heart River Bend Medical Center Springfield Oregon United States 94777
    10 York Hospital York Pennsylvania United States 17405
    11 University of Washington Medical Center Seattle Washington United States 91895

    Sponsors and Collaborators

    • Saint Luke's Health System
    • Boston Scientific Corporation

    Investigators

    • Principal Investigator: J. Aaron Grantham, MD, Saint Luke's Health System

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Saint Luke's Health System
    ClinicalTrials.gov Identifier:
    NCT02026466
    Other Study ID Numbers:
    • OPEN CTO V1.2
    First Posted:
    Jan 3, 2014
    Last Update Posted:
    Oct 19, 2021
    Last Verified:
    Oct 1, 2021
    Keywords provided by Saint Luke's Health System
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 19, 2021